Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (9)
  • 2025 (37)
  • 2024 (52)
  • 2023 (76)
  • 2022 (59)
  • 2021 (36)
  • 2020 (8)
  • 2019 (2)

Subject

  • Drug Trafficking (4124)
  • Synthetic drugs (1103)
  • Guns/Weapons (1015)
  • OCDETF/Task Force (817)
  • Fake Pills (672)
  • Arrests/Convictions - Major (630)
  • Guilty Plea (541)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (371)
  • Overdose (325)
  • Major Law Enforcement Operation (275)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (227)
  • Money Laundering (210)
  • Gangs (200)
  • Outreach/Drug Prevention (187)
  • Fentanyl Awareness (160)
  • One Pill Can Kill (115)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Counterfeit Pills (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Fentanyl Free America (27)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (12)
  • Other (11)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (253)
  • Asset Forfeiture (29)

Drug Name

  • Opioids (43)
  • Fentanyl (42)
  • Oxycodone (39)
  • Hydromorphone (16)
  • Methamphetamine (15)
  • Cocaine (12)
  • Synthetic Opioids (11)
  • Benzodiazepines (9)
  • Morphine (7)
  • Heroin (6)
  • Marijuana (Cannabis) (6)
  • Amphetamines (4)
  • Methadone (3)
  • Steroids (3)
  • Ecstasy/MDMA (1)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Washington, DC (38)
  • New England (35)
  • Chicago (27)
  • Seattle (26)
  • New York (23)
  • Houston (16)
  • New Jersey (14)
  • Atlanta (13)
  • Miami (13)
  • New Orleans (12)
  • Sede (10)
  • St. Louis (9)
  • El Paso (8)
  • San Francisco (8)
  • Rocky Mountain (6)
  • Dallas (5)
  • Phoenix (4)
  • Los Angeles (3)
  • Omaha (3)
  • San Diego (3)
  • Louisville (2)
  • Detroit (1)
Clear All Results
279 Results - Showing 51 to 60
PRESS RELEASE

Hospital in Washington Agrees to Pay $15,000 Penalty and Implement Corrective Actions to Address Theft of Controlled Substances

Spokane, Wash. - Mid-Valley Hospital and Clinic in Omak, Washington, agreed to pay a $15,000 Controlled Substances Act penalty and to institute corrective actions in regard to its pharmacy and controlled substances policy and procedures. To protect the public, the Controlled Substances Act and its implementing regulations place legal responsibilities...
PRESS RELEASE

Nearly 630,000 Pounds of Unneeded Medications Collected on DEA’s National Prescription Drug Take Back Day

MIAMI — Drug Enforcement Administration (DEA) and more than 4,400 law enforcement partners recently collected nearly 630,000 pounds of unused medications at 4,600 locations nationwide. This effort to empty medicine cabinets helps prevent drug misuse before it starts. Since its inception, DEA’s National Prescription Drug Take Back Day has removed...
PRESS RELEASE

Multi-Kilogram Methamphetamine and Fentanyl Dealer Sentenced to 19 years in Federal Prison

Orlando, Fla. – U.S. District Judge Paul G. Byron today sentenced George Pherai-Bogeajis, 35, Orlando, to 19 years and 7 months in federal prison for conspiring to distribute methamphetamine and fentanyl and possessing firearms in furtherance of drug trafficking. The court also ordered Pherai-Bogeajis to forfeit four vehicles and four...
PRESS RELEASE

Covetrus Agrees To Pay $1,125,000 for Failing to Adequately Address Suspicious Opioid Orders and for Inadequate Recordkeeping Practices

BOSTON – The U.S. Attorney’s Office has reached a $1,125,000 settlement with Covetrus North America, LLC (Covetrus NA) to resolve allegations that it violated the Controlled Substances Act and related regulations. Covetrus NA, headquartered in Portland, Maine, is a company that distributes veterinary medicine to customers worldwide. Under the settlement...
PRESS RELEASE

Physician, Physician Assistant, and Practice Pay $300K to Resolve Controlled Substances Act Allegations

BERLIN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Dr. STEVEN SHIFREEN, Physician Assistant CHRISTOPHER NORVAL, and MULTICARE MUSCULOSKETETAL MEDICINE AND PAIN MANAGEMENT ASSOCIATES, P.C...
PRESS RELEASE

Former Nurse Pleads Guilty in Connection with Diverting Fentanyl from ICU Patient

CONCORD, N.H. – A Northfield woman has pleaded guilty in federal court for diverting fentanyl from an ICU patient at Concord Hospital, U.S. Attorney Jane E. Young announces. Lisa Richardson, 48, pleaded guilty to one count of Tampering with Consumer Products. U.S. District Court Judge Landya McCafferty scheduled sentencing for...
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
PRESS RELEASE

Civil Settlement Resolves Allegations of Record-keeping Violations Against Savannah-area Weight Loss Physician

SAVANNAH, GA: A physician who operates weight-loss clinics in the Savannah area has agreed to pay civil penalties and to accept increased oversight to resolve allegations that he violated the Controlled Substances Act. Dr. Donald Lyle Gates, who operates three Savannah-area Scale Solutions clinics, reached a settlement with the Southern...
PRESS RELEASE

Boston Physician Resolves Allegations Of Improper Prescribing Practices Involving Controlled Substances

BOSTON – A physician who practiced at Brigham and Women’s Hospital has agreed to pay $25,000 in civil penalties to settle allegations that he violated the Controlled Substances Act by prescribing opioid controlled substances outside the usual course of professional practice. As part of the settlement agreement, Dr. Edgar Ross...
PRESS RELEASE

Members of a Houston-Based Organization Responsible for Breaking Into Pharmacies in Rural Iowa and Nebraska Indicted

OMAHA, Neb – Five members of a Houston-based organization known for targeting rural pharmacies in Western Iowa and Western Nebraska face federal charges after breaking in and stealing pharmaceuticals in May and June of 2022 and 2023. These five people are part of a larger conspiracy being prosecuted out of...

Paginación

  • Primera página «
  • Anterior
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster